Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371320100790050405
Journal of the Korean Surgical Society
2010 Volume.79 No. 5 p.405 ~ p.410
Five-year Survival and Prognostic Factors after Kasai Portoenterostomy for Biliary Atresia
Hong A-Rum

Jung Eun-Young
Kang Yu-Na
Choi Soon-Ok
Park Woo-Hyun
Abstract
Purpose: Long-term survival of biliary atresia patients after Kasai¡¯s portoenterostomy is being increasingly reported. Although extended survival has been achieved for many patients, factors influencing outcome have not been defined clearly. The authors investigated 5-year survival rates and prognostic factors for survival after Kasai¡¯s portoenterostomy using univariate and multivariable methods.

Methods: The authors analyzed 5-year survival rates and prognostic factors in 56 patients who underwent Kasai¡¯s portoenterostomy during the period from 1991 to 2005 by the Kaplan-Meier model and Cox proportional hazards model, respectively. Both clinical factors and histological features of the liver and periportal fibrous mass were analyzed as prognostic factors.

Results:Younger ages of less than 90 days at surgery, clearance of jaundice and absence of post-Kasai cholangitis in 6 months were predictive of a favorable outcome. A significant difference between the live and the dead was found with regard to an average of 7 or more bile ductules in periportal fibrous mass in 200 HPF (P=0.013). The external diameter of the longest bile ductule in the periportal fibrous mass is not correlated to the prognosis (P=0.49). Independent factors for good prognosis were jaundice-free in 6 months and over 7 bile ductules density in periportal fibrous mass.

Conclusions: Favorable outcome after Kasai¡¯s portoenterostomy for biliary atresia is determined by bilirubin clearance in 6 months after Kasai operation and seven or more bile ductules in periportal fibrous mass. The 5-year post-Kasai survival rate is 77.2%.
KEYWORD
Biliary atresia, Kasai procedure, Prognosis, Survival
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø